FDA Approves Test to Differentiate HIV Viruses

Share this content:
FDA Approves Test to Differentiate HIV Viruses
FDA Approves Test to Differentiate HIV Viruses

FRIDAY, July 24, 2015 (HealthDay News) -- A new diagnostic to differentiate between HIV-1 antibodies, HIV-2 antibodies, and HIV-1 p24 antigen in human serum or plasma specimens has been approved by the U.S. Food and Drug Administration.

The Bio-Rad BioPlex 2200 HIV Ag-Ab assay is approved for people aged two years and older, including pregnant women. The test can be used to screen organ donors for the two major types of HIV (HIV-1 and HIV-2), but it's not been approved to routinely screen donated blood or plasma for the virus, the agency said.

While cases of HIV-2 have been diagnosed in the United States, HIV-2 has been found primarily in West Africa, the FDA said. Most cases in the United States have been linked to HIV-1. The viruses are similar yet distinct.

"Today's approval provides health care professionals another option for the diagnosis of HIV infections," Karen Midthun, M.D., director of the FDA's Center for Biologics Evaluation and Research, said in a statement. "The ability to diagnose HIV infection early and differentiate between types of infection is important in the care of individuals as both diseases exhibit the same symptoms but progress at different rates."

The new diagnostic is produced by Bio-Rad Laboratories, based in Hercules, Calif.

More Information

Share this content:

is free, fast, and customized just for you!

Already a member?

Sign In Now »


Sign up for myCME e-newsletters


Drug Lookup

Browse drugs by: BrandGenericDisease


More in Home

ASTRO: No Survival Benefit for Adding EBT to Brachytherapy

ASTRO: No Survival Benefit for Adding EBT to ...

Addition of external beam therapy doesn't improve five-year progression-free survival in prostate cancer

ASTRO: Fewer Side Effects With IMRT in Cervical, Endometrial CA

ASTRO: Fewer Side Effects With IMRT in Cervical, ...

Patients in conventional radiotherapy arm had more high-level adverse events than those in IMRT arm

Many Doctors Reluctant to Reveal Mental Health Issues

Many Doctors Reluctant to Reveal Mental Health Issues

Perceived stigma, fear of career repercussions hinder treatment, study suggests

is free, fast, and customized just for you!

Already a member?

Sign In Now »